ARCHIVES

‘We Cannot Tolerate One Third Reduction In Centers. Prevention, Clinical Trials Programs’

This article is from The Cancer Letter archive.

Vol. 17 No. 36 | September 20, 1991

Download PDF Visit The Full Archive

Related Articles

Science Policy: Increased Cancer Death Rate For Atomic Vets Not Significant, OIM Says

October 29, 1999

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

September 26, 2008

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

Women’s Health: Treatment to Move Toward Pre-Cancer, Klausner Says

December 5, 1997

60 Minutes To Air Segment On The “Deception at Duke”

February 10, 2012

In Brief: Durant Says He Expects Comprehensive Centers Lineup to Change With New System

December 15, 1989